Skip to main content
Industry News
Groups to develop ovarian cancer companion diagnostic
2/22/2021

AmoyDx of China will collaborate with AstraZeneca in developing a companion diagnostic for ovarian cancer with homologous recombination deficiency. Financial details of the agreement were not disclosed.

Full Story: